Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Other financing activities (2020 - 2024)

Fennec Pharmaceuticals (FENC) has disclosed Other financing activities for 7 consecutive years, with $1.7 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Other financing activities changed N/A year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Dec 2024, changed N/A, and an annual FY2024 reading of $1.7 million, up 57900.0% over the prior year.
  • Other financing activities was $1.7 million for Q1 2024 at Fennec Pharmaceuticals, up from $196000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.7 million in Q1 2024 and bottomed at $42000.0 in Q2 2021.
  • Average Other financing activities over 4 years is $523750.0, with a median of $156500.0 recorded in 2020.